Similarly, multiple Ig fusion proteins, including PD-L1 and CTLA-4 Ig fusion proteins, were developed to suppress co-stimulatory interactions, resulting in protection against MS/EAE and considerable disease amelioration. Here, CTLA4 is linked to myeloid sarcoma.